Business and Technology News

Business, Life Sciences, and Technology News

The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. Big Pharma companies are focusing on vaccine development and a slew of biotechs are testing compounds, previously intended for a wide range of indications, as potential COVID-19 treatments. This week saw another major development brought on by industry efforts to adjust to […]

Telemedicine giant Teladoc Health is buying health technology company Livongo Health in an $18.5 billion cash and stock deal that comes as the COVID-19 pandemic drives patients to seek ways to manage their health from home. Teladoc (NYSE: TDOC) provides “virtual healthcare services” that give patients the ability to visit with a doctor remotely. Most […]

One of the challenges facing cell therapy developers is collecting enough cells to produce a viable treatment. It’s a particularly pronounced problem for therapies employing regulatory T cells (Tregs), a type of immune cell that’s relatively scarce in the blood, says GentiBio CEO Adel Nada. Some biotech companies are developing Treg cell therapies from a […]

A partnership between Voyager Therapeutics and AbbVie developing gene therapies for Alzheimer’s and Parkinson’s disease has ended without a drug for either disease reaching human testing. Voyager (NASDAQ: VYGR) announced the termination of the research pact after market close Monday. The Cambridge, MA-based biotech is keeping full rights to its technology for using engineered viruses […]

Kymera Therapeutics has a pipeline of preclinical drug candidates that use an experimental approach to get rid of disease-causing proteins and it’s now looking to tap the public markets to finance tests of the technology in humans. In paperwork submitted to the Securities and Exchange Commission on Friday, Kymera set a $100 million goal for […]

Another biopharma has signed up to use Sangamo Therapeutics’ gene editing technology to develop therapies that can address disease by heightening or depressing a gene’s activity level. Sangamo on Thursday announced that Novartis (NYSE: NVS) had agreed to shell out $75 million up front to leverage the biotech’s genome regulation technology to treat certain neurodevelopmental […]

Tech companies that have long competed for talent by offering tricked-out offices and unlimited vacation days are adding a new perk: money for the home office. Facebook yesterday became the latest...

To view the full story, click the title link.

A new book argues that the stratification in quality of life between New York’s rich and poor neighborhoods is at least partially the result of real estate agents.  “Agents’ work in shaping buyers’...

To view the full story, click the title link.

New York schools can bring children back to classrooms for the start of the school year, Gov. Andrew Cuomo announced Friday, citing success in battling the coronavirus in the state that once was the...

To view the full story, click the title link.

The Department of Financial Services on Wednesday issued guidance to health insurers to ensure that patients are not charged for the personal protective equipment used by health care...

To view the full story, click the title link.

Working from home during a pandemic is hard enough. Now many across the Northeast are being forced to do it without electricity. More than 1.2 million homes and businesses from New York to Delaware...

To view the full story, click the title link.

The move could hamstring the Chinese tech giant if it prevents the firm’s customers from getting the latest versions of services such as Maps and Gmail.

Shareholders are voting on whether to push the tech giant to examine the human rights and financial risks of the surveillance technology.

Artificial intelligence may help doctors make more accurate readings of CT scans used to screen for lung cancer.

The great hope for people without a bachelor’s degree hasn’t yet spread beyond small-scale success stories.

When it comes to disinformation, all signs suggest the 2020 presidential campaign will make 2016 look like a mere test run, our columnist writes.

The price was relatively small, but the deal may have a big impact on the race between the United States and China to build more powerful computers.